ArticleMovement disorders clinical practice2025
Chewing Dystonia and Sensory Modulation: An Exploratory Study of Intraoral Lidocaine Effects.
Article in Movement disorders clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChewing dystonia is a rare, task-specific oromandibular dystonia that causes involuntary jaw and tongue movements during mastication and often refractory to standard treatments for dystonia. Emerging evidence suggests that peripheral sensory modulation may play a role in dystonia pathophysiology, but this has not been systematically evaluated as potential treatment modality.
objectivesThe aim of this study was to explore the therapeutic and neurophysiological effects of intraoral topical lidocaine in patients with task-specific chewing dystonia.
methodsThis prospectively documented exploratory case series included 6 patients (4 Yemeni males, 2 Indian females), with chewing dystonia unresponsive to medications or botulinum toxin. Two cases were previously reported; 4 were subsequently documented using a uniform clinical protocol. Unified Dystonia Rating Scale (UDRS) scores were assessed before and after intraoral lidocaine during chewing of hard and soft foods. All patients were video recorded; 3 underwent electromyography (EMG). Burst duration and root mean square amplitude were analyzed. Wilcoxon signed-rank tests assessed significance.
resultsMean UDRS scores improved significantly for both hard-consistency foods (7.17 ± 0.75 to 3.83 ± 0.69; P = 0.031) and soft-consistency foods (4.6 ± 0.62 to 2.25 ± 0.96; P = 0.031). Inter-rater reliability was high. EMG data showed reductions in root mean square (RMS) amplitude ranging between 18.6% and 36.5% across 3 patients alongside visual shortening of burst durations. Symptom relief occurred within minutes, lasted 60-90 minutes, and was observed across both balm and spray formulations without adverse effects.
conclusionsIntraoral lidocaine may provide rapid, noninvasive relief in task-specific chewing dystonia. These findings support further investigation into sensory-based therapeutic approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.